phenyl acetate has been researched along with Hematologic Malignancies in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dadwal, SS; Dickter, JK; Lee, BV; Ross, JA; Tegtmeier, BR; Zain, JM | 1 |
| Besley, L; Mortimore, R; Wheller, L | 1 |
| Peggs, KS; Sellar, RS | 1 |
| Burns, L; Chai, X; Cheng, GS; Chien, JW; Flowers, MED; Ho, VT; Inamoto, Y; Jacobsohn, DA; Jagasia, M; Johnston, L; Lee, SJ; Martin, PJ; Mayer, S; Palmer, J; Pavletic, SZ; Pidala, J; Pusic, I; Storer, BE; Williams, KM | 1 |
| Akimoto, M; Honma, Y; Ishii, Y; Ishikura, H; Kiyota, H; Tsumura, H | 1 |
1 review(s) available for phenyl acetate and Hematologic Malignancies
| Article | Year |
|---|---|
Therapeutic strategies for cytomegalovirus infection in haematopoietic transplant recipients: a focused update.
Topics: Acetates; Antiviral Agents; Benzimidazoles; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunotherapy, Adoptive; Organophosphonates; Quinazolines; Ribonucleosides; T-Lymphocytes; Transplant Recipients; Transplantation, Homologous | 2014 |
1 trial(s) available for phenyl acetate and Hematologic Malignancies
| Article | Year |
|---|---|
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.
Topics: Acetates; Adult; Aged; Anti-Inflammatory Agents; Azithromycin; Bronchiolitis Obliterans; Cyclopropanes; Disease Progression; Fluticasone; Forced Expiratory Volume; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lung; Male; Middle Aged; Quality of Life; Quinolines; Sulfides; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2016 |
3 other study(ies) available for phenyl acetate and Hematologic Malignancies
| Article | Year |
|---|---|
Letermovir and maribavir for pan-resistant cytomegalovirus infection in a patient with haematologic malignancy: Consideration for combination therapy.
Topics: Acetates; Adult; Antiviral Agents; Benzimidazoles; Cytomegalovirus; Cytomegalovirus Infections; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Quinazolines; Ribonucleosides | 2022 |
Effective treatment of eosinophilic dermatosis of haematological malignancy with montelukast.
Topics: Acetates; Cyclopropanes; Eosinophils; Hematologic Neoplasms; Humans; Paraneoplastic Syndromes; Quinolines; Skin Diseases; Sulfides; Treatment Outcome | 2021 |
Gene expression profiles in differentiating leukemia cells induced by methyl jasmonate are similar to those of cytokinins and methyl jasmonate analogs induce the differentiation of human leukemia cells in primary culture.
Topics: Acetates; Cell Differentiation; Cyclopentanes; Cytokinins; Esters; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; HL-60 Cells; Humans; Isopentenyladenosine; Leukemia; Oxylipins; Tumor Cells, Cultured | 2009 |